Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-19

Clinical Trial Update: Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year [Phase 3]

View source ↗

Summary

Phase 3 trial update on tirasemtiv in amyotrophic lateral sclerosis with longitudinal assessment after one year; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirasemtiv (tirasemtiv)

Snippet

Sponsor: Cytokinetics | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2020-06-19